Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

Elihu H. Estey, Francis J. Giles, Miloslav Beran, Susan O'Brien, Sherry A. Pierce, Stefan H. Faderl, Jorge E. Cortes, Hagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

154 Scopus citations

Fingerprint Dive into the research topics of 'Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds